Tag - remdesivir

 
Menu
Search
 
July 12, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

REMDESIVIR

Japan Times
WORLD / Science & Health
Nov 20, 2020
WHO advises doctors not to use Gilead’s remdesivir for COVID-19
The recommendation is a blow to Gilead's drug, which was one of the first thought to offer a meaningful benefit in treatment of coronavirus patients.
Japan Times
BUSINESS / Companies
Jun 23, 2020
Gilead targets remdesivir supply for 2 million COVID-19 patients by year-end
The company also said it hoped to start trials in August of an easier-to-use inhaled version of the medicine, which is currently administered only intravenously.
Japan Times
WORLD / Science & Health
May 23, 2020
Gilead’s remdesivir mainly helped healthier COVID-19 patients
Gilead Sciences Inc.’s remdesivir, the first medicine cleared for the treatment of COVID-19, mainly benefited healthier patients who weren’t dependent on ventilators or heart-lung bypass machines, according to published results of the study used to get the medicine on the market.
Japan Times
ASIA PACIFIC / Science & Health
May 13, 2020
A tale of two Japanese drugs in tests to fight COVID-19
Avigan and camostat are undergoing trials as they may be effective in treating illnesses brought on by coronavirus.
Japan Times
JAPAN / FOCUS
May 12, 2020
Abe follows Trump's example, approving drugs quickly after criticism
Japanese regulators are usually known for taking a year to approve new drugs, but authorized remdesivir just three days after receiving the application.
Japan Times
WORLD / Science & Health
May 2, 2020
U.S. emergency approval broadens use of Gilead's COVID-19 drug remdesivir
Gilead Science Inc.'s antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday, clearing the way for broader use of the drug in more hospitals around the United States.
Japan Times
WORLD / Science & Health
May 1, 2020
Virus drugmaker caught between making a profit and treating the world
Gilead Sciences Inc. may spend $1 billion on its breakthrough new treatment for COVID-19 this year alone, Chief Executive Officer Daniel O’Day said. How much revenue — if any — the company expects to generate is another matter.
Japan Times
WORLD / Science & Health
Apr 11, 2020
Two-thirds of severe COVID-19 cases improved with remdesivir drug
Gilead Sciences Inc.’s experimental drug for patients with severe COVID-19 infections showed promise in an early analysis, raising tentative hope that the first treatment for the novel virus may be on the horizon.
Japan Times
WORLD / Science & Health / FOCUS
Apr 6, 2020
Fast-moving virus pits treating patients against finding a cure
Pharmaceutical research experts are raising concerns that attempts to offer desperate coronavirus patients some form of treatment may hobble crucial studies of which drugs actually work and which ones don't.
JAPAN / Science & Health
Mar 24, 2020
Japan to join trial to test Ebola drug on COVID-19 patients
The National Center for Global Health and Medicine (NCGM) said Monday that it will join an international clinical trial on the use of remdesivir, which is being developed as a remedy for Ebola, to treat people infected with the new coronavirus.
BUSINESS
Feb 26, 2020
U.S. begins first coronavirus clinical trial testing Gilead's experimental drug
U.S. health officials said on Tuesday the first clinical trial testing Gilead Sciences Inc.'s experimental antiviral drug, remdesivir, in hospitalized patients with the coronavirus has started.
Japan Times
ASIA PACIFIC / Science & Health
Feb 14, 2020
Gilead drug prevents type of coronavirus in monkeys, raising hope for China trials
An experimental Gilead Sciences antiviral drug prevented disease and reduced the severity of symptoms in monkeys infected with Middle East respiratory syndrome (MERS), an infection closely related to the fast-spreading coronavirus that originated in China, a study published on Thursday found.
Japan Times
MULTIMEDIA
Feb 24, 2015
Ebola drug developed in Japan 'halved mortality rates' in some Guinea patients
A relatively cheap drug from a subsidiary of Fujifilm being tested against Ebola in Guinea has halved mortality rates in some patients.
Tokyo hit by torrential rainfall at rush hour
People line up at Shibuya Station in Tokyo as they try to avoid the heavy rain on Thursday.
Foreign drivers in Japan to face tougher license conversion rules from October
According to the National Police Agency, there were 75,905 people who converted their foreign driver’s license to a Japanese one in 2024, up from 48,885 in 2019.
Chinese fighters came within 30 meters of Japanese spy aircraft, Tokyo says
A Chinese JH-7 fighter jet makes an near an Air Self-Defense Force YS-11EB surveillance aircraft over the East China Sea this week in this image released Thursday.
Air India crash report to offer peek into last seconds
Members of the Indian Army's engineering arm prepare to remove the wreckage of an Air India aircraft in Ahmedabad on June 14.
What Japanese politics could look like after Upper House election
Prime Minister Shigeru Ishiba, who heads the ruling Liberal Democratic Party (center) waves to attendees as he departs after delivering a campaign speech in Yokohama on Sunday.
New IG Arena set to dial down temperature at Nagoya Basho, in a good way
With IG Arena getting glowing early reviews as the Nagoya Basho’s replacement venue, it may be a while before fans wax nostalgic about the Aichi Prefectural Gymnasium.
Once a niche, anime is now mainstream content for Netflix and other streaming services
Though Netflix remains the dominant choice globally for anime viewers, Amazon Prime Video has also invested heavily in anime, steadily adding titles to their catalogue.
NGOs condemn rise in anti-immigrant rhetoric ahead of Upper House vote
Sanseito head Sohei Kamiya holds a board that reads "Japanese First" in Tokyo on July 2. In a joint statement on Tuesday, eight human rights nongovernmental organizations described the far-right party's stance as "hate speech."
Japanese dancers find a home abroad at Houston Ballet
“Giselle” lead Yuriko Kajiya (center), performing with Connor Walsh as Albrecht, is one of six Japanese dancers at Houston Ballet.
From the Abes to the Ohtanis: How siblings shape athletic development
Olympic judoka Uta Abe (second from left) and Hifumi Abe (second from right) with their brother Yuichiro (center) and their parents. “I’m always consciously trying to be a good older brother,” Yuichiro said.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Mount Fuji is considered one of Japan's most iconic symbols and is a major draw for tourists. It's still a mountain, though, and potential hikers need to properly prepare for any climb.
What it takes to save lives on Mount Fuji
By Alex K.T. Martin

SUSTAINABLE JAPAN

Muji has been sustainable from the beginning
Muji has been sustainable from the beginning

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER